Month: February 2017

IDIBELL and the Integral Health Consortium begin a research integration process

Last Tuesday, February 21st, the management of the Bellvitge Biomedical Research Institute (IDIBELL) and the Integral Health Consortium (IHC) presented the agreement that regulates the first phase of the collaboration process between both entities. The final aim of this process is to establish a relationship framework for the integration of IHC research into IDIBELL, a …

IDIBELL and the Integral Health Consortium begin a research integration process Read More »

Women and science: past, present and future

On Friday, February 10th, the Equality Committee of the Bellvitge Biomedical Research Institute of Bellvitge (IDIBELL) organized the round table “Women and Science: present, past and future” to celebrate the International Women Science Day (February 11th). This date is the one chosen by the United Nations to promote the career prospects of women in science …

Women and science: past, present and future Read More »

Conference on health technologies within the Mobile World Congress framework

On Thursday 9th February, the hall of the Bellvitge University Hospital hosted the conference “Technology for health and medical research”, a session within the third edition of the cycle “The Mobile communications revolution” of the Mobile World Congress. The event was sponsored by the City of Hospitalet de Llobregat and GSMA, the organizer of the …

Conference on health technologies within the Mobile World Congress framework Read More »

Bastos Medical, committed to IDIBELL’s ovarian cancer research

Each year more than 3,000 new cases of ovarian cancer are diagnosed in Spain, and about 2,000 women die from this disease. This high mortality rate is due in large part to a late diagnosis, made when the disease is advanced, and / or to the lack of accurate treatments. In order to advance in …

Bastos Medical, committed to IDIBELL’s ovarian cancer research Read More »

Scroll to Top